Author

Bruce L. Daugherty

Tonix Pharmaceuticals (United States)ORCID 0000-0003-2875-3920Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Arnold S. HaniD· 1 shared Biyun ZhengiD· 1 shared Chenkai MaiD· 1 shared Christine S. MooniD· 1 shared David W Harle· 1 shared Feijing WuiD· 1 shared Hiroki KobayashiiD· 1 shared Hualong ZhengiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Arnold S. HanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer CellPeer-reviewedOct 11, 2024

A CXCR4 partial agonist improves immunotherapy by targeting polymorphonuclear myeloid-derived suppressor cells and cancer-driven granulopoiesis

Jin Qian, Chenkai Ma, Quin T. Waterbury…·Timothy Cragin Wang

This paper shows that a CXCR4 partial agonist enhances immunotherapy in gastric cancer by targeting PMN-MDSCs and granulopoiesis.

26 citationstop 4%

𝕏 PostBluesky